Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Unlimited Watchlists, Portfolios, Screeners, and other Barchart tools. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Biotricity Inc (BTCY)

Biotricity Inc (BTCY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,532
  • Shares Outstanding, K 51,277
  • Annual Sales, $ 7,650 K
  • Annual Income, $ -29,130 K
  • 60-Month Beta 1.70
  • Price/Sales 7.99
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BTCY with:

Options Overview Details

View History
  • Implied Volatility 407.31% ( -167.94%)
  • Historical Volatility 72.93%
  • IV Percentile 85%
  • IV Rank 33.07%
  • IV High 1,130.42% on 05/26/22
  • IV Low 49.99% on 01/20/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 37
  • Put/Call OI Ratio 0.03
  • Today's Open Interest 1,823
  • Open Int (30-Day) 1,547

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -62.50%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0700 +10.28%
on 08/01/22
1.5400 -23.38%
on 07/21/22
-0.1800 (-13.24%)
since 07/15/22
3-Month
0.9500 +24.21%
on 05/27/22
1.9229 -38.63%
on 06/30/22
+0.0800 (+7.27%)
since 05/16/22
52-Week
0.9500 +24.21%
on 05/27/22
5.3000 -77.74%
on 12/28/21
-2.2700 (-65.80%)
since 08/16/21

Most Recent Stories

More News
Analysts Offer Insights on Technology Companies: Upland Software (UPLD) and Biotricity (BTCY)

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Upland Software (UPLD – Research Report) and Biotricity (BTCY – Research Report) with bullish sentiments....

BTCY : 1.1800 (-1.67%)
UPLD : 11.74 (+5.10%)
Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year

Company Reports Record Revenue and Improved Margins

BTCY : 1.1800 (-1.67%)
Biotricity to Join Russell Microcap(R) Index

REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the...

BTCY : 1.1800 (-1.67%)
Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th

REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present and...

BTCY : 1.1800 (-1.67%)
Biotricity Issues Shareholder Update

Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.

BTCY : 1.1800 (-1.67%)
Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022

- Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc. (NASDAQ:BTCY)...

BTCY : 1.1800 (-1.67%)
Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022

Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity"...

BTCY : 1.1800 (-1.67%)
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th

- Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared, wireless,...

BTCY : 1.1800 (-1.67%)
Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device

- Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity"...

BTCY : 1.1800 (-1.67%)
Biotricity Releases Fiscal 2022 Third Quarter Financial Results

Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End...

BTCY : 1.1800 (-1.67%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Biotricity Inc. is a medical technology company. It focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post-diagnostic solutions for chronic conditions and lifestyle improvement. Biotricity Inc. is based in Toronto, Canada....

See More

Key Turning Points

3rd Resistance Point 1.2800
2nd Resistance Point 1.2400
1st Resistance Point 1.2200
Last Price 1.1800
1st Support Level 1.1600
2nd Support Level 1.1200
3rd Support Level 1.1000

See More

52-Week High 5.3000
Fibonacci 61.8% 3.6383
Fibonacci 50% 3.1250
Fibonacci 38.2% 2.6117
Last Price 1.1800
52-Week Low 0.9500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar